← Browse by Condition
Medical Condition

chemotherapy

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for chemotherapy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — chemotherapy Clinical Trials

How many clinical trials are currently recruiting for chemotherapy?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for chemotherapy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for chemotherapy?
chemotherapy research spans Phase 1 (2 trials), Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a chemotherapy clinical trial?
Eligibility criteria for chemotherapy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
2
Top Sponsors
Hsin Yi Lu 1 trial
Peking University First Hospital 1 trial
The First Affiliated Hospital of Zhengzhou University 1 trial
Nanfang Hospital, Southern Medical University 1 trial
Lebanese University 1 trial

Recruiting Clinical Trials

NCT06541587
Recruiting
Smart VR Mindfulness for Breast Cancer: Integrating Biofeedback and Evaluating Chemotherapy Effectiveness
Enrollment
60 pts
Location
Taiwan
Sponsor
Hsin Yi Lu
View Trial →
NCT06864533
Recruiting
Adjuvant Chemotherapy for High Malignant Prostate Cancer
Enrollment
315 pts
Location
China
Sponsor
Peking University First Hospit...
View Trial →
NCT06896422 Phase 1
Recruiting
Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLC
Enrollment
80 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT05825443 Phase 2
Recruiting
Adjuvant Chemotherapy Combined With Camrelizumab for ⅡA -ⅢA NSCLC Patients
Enrollment
57 pts
Location
China
Sponsor
Nanfang Hospital, Southern Med...
View Trial →
NCT06307249 Phase 1
Recruiting
Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA
Enrollment
50 pts
Location
Lebanon
Sponsor
Lebanese University
View Trial →
NCT04891016 Phase 2
Recruiting
Toripalimab Plus FLOT in Locally Advanced Gastric Cancer
Enrollment
60 pts
Location
China
Sponsor
Henan Cancer Hospital
View Trial →
NCT07276932
Recruiting
Clinical Study of Acupoint Application on Relieving qi Deficiency and Constipation in Patients Undergoing Chemotherapy
Enrollment
106 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT06168032
Recruiting
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Enrollment
1,224 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →

Related Conditions

breast cancer (2) immunotherapy (2) lung cancer (2) immune checkpoint inhibitor (2) virtual reality (1) mindfulness (1) prostate cancer (1) radiation therapy (1) gleason score (1) non small cell lung cancer (1) pd1 antibody (1) glutathione (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology